ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,365Medicare Part D Prescriptions Filled, Including Refills

Rank: 106 out of 783

$793K Total Retail Price of All Prescriptions

Rank: 98 out of 783

599 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

29% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 8,385 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 786 441 S3 1 2
AMLODIPINE BESYLATE 580 438 2 5
LISINOPRIL 454 322 3 4
OMEPRAZOLE 425 224 4 6
LEVOTHYROXINE SODIUM 401 230 5 1
SIMVASTATIN 386 223 6 3
METFORMIN HCL 272 173 7 8
FUROSEMIDE 261 216 8 7
GABAPENTIN 259 160 9 15
METOPROLOL SUCCINATE 203 149 10 13
CARVEDILOL 197 144 11 21
HYDROCHLOROTHIAZIDE 194 158 12 12
LOSARTAN POTASSIUM 177 132 13 18
CYMBALTA 161 65 14 35
ZOLPIDEM TARTRATE 160 117 15 23
WARFARIN SODIUM 157 132 16 10
GLIMEPIRIDE 155 130 17 34
MELOXICAM 152 67 18 37
METOPROLOL TARTRATE 145 98 19 9
ATORVASTATIN CALCIUM 145 109 19 11
TRAZODONE HCL 138 51 21 39
SERTRALINE HCL 133 105 22 22
DONEPEZIL HCL 121 107 23 24
POTASSIUM CHLORIDE 117 86 24 16
CITALOPRAM HBR 114 80 25 19
NEXIUM 113 71 26 28
ESCITALOPRAM OXALATE 109 62 27 54
CRESTOR 104 55 28 27
PROAIR HFA 104 45 28 56
CLOPIDOGREL 100 81 30 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 72 30 33
PRAVASTATIN SODIUM 96 58 32 14
PANTOPRAZOLE SODIUM 93 57 33 30
FLUOXETINE HCL 93 51 33 45
ENALAPRIL MALEATE 90 50 35 68
CYCLOBENZAPRINE HCL 90 18 R 35 63
SYMBICORT 87 53 37 157
RANITIDINE HCL 86 39 38 44
CLONIDINE HCL 85 55 39 60
PAROXETINE HCL 84 41 40 69
LYRICA 80 39 41 98
ATENOLOL 76 41 42 17
PLAVIX 76 64 42 51
SPIRIVA 73 49 44 59
LANTUS 73 54 44 38
TRAMADOL HCL 71 46 46 20
POLYETHYLENE GLYCOL 3350 67 26 47 43
RAMIPRIL 66 50 48 113
ACTOS 65 32 49 149
TIZANIDINE HCL 65 22 49 133
ALENDRONATE SODIUM 65 64 49 25
FLUTICASONE PROPIONATE 62 28 52 46
KLOR-CON M20 62 23 52 48
SINGULAIR 61 31 54 90
DIGOXIN 59 47 55 61
ALLOPURINOL 56 40 56 31
GLIPIZIDE ER 55 43 57 84
JANUVIA 54 40 58 73
OXYBUTYNIN CHLORIDE ER 53 24 59 117
HUMALOG 52 28 60 101
OXYCODONE HCL-ACETAMINOPHEN 52 25 S2 60 86
ROPINIROLE HCL 52 33 60 74
NAMENDA 51 49 63 32
CELEBREX 51 39 63 93
SPIRONOLACTONE 51 37 63 57
DIOVAN 50 40 66 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.